fbpx Skip to main content
 

Search

Janssen Search

Search results

256 SEARCH RESULTS FOR

faxtor 11 phase 3

Not finding what you're looking for? Visit Janssen in your country.
PAGE 19 OF 26

Pages

Maximizing the Impact of our Awareness and Development Efforts for an Investigational Ebola Vaccine in Sierra Leone The road to the EBOVAC-Salone clinic in Kambia, Sierra Leone The clinic, in Kambia, Sierra Leone, where the EBOVAC-Salone trial took place. ...

PASCALE MARTY-ETHGEN, PHARM.D., PH.D. VICE PRESIDENT PORTFOLIO MANAGEMENT AND EXTERNAL INNOVATION Pascale Marty-Ethgen, Pharm.D., Ph.D. is Vice President, Immunology Therapeutic Area Portfolio Management and External Innovation Leader for Janssen Research ...

Jan 22, 2024 United States Data illustrates rapid and significant clearance in moderate to severe scalp psoriasis and significant improvement in scalp itch, as well as patient-reported health-related quality of life outcomes, including post-inflammatory ...

Bacterial Infections We refuse to stand still while bacterial infections continue to evade our control. Structure of E. coli We are working urgently to help protect society from the consequences of Extraintestinal Pathogenic E. coli (ExPEC) and ...

Mar 01, 2023 United States Niraparib and Abiraterone Acetate Plus Prednisone Has Potential to Address Unmet Need for Patients with BRCA-Positive mCRPC   RARITAN, N.J., February 28, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today ...

Welcome to the Johnson & Johnson Gastroenterology Newsroom! Below, please find the latest on our Gastroenterology news, a message from our leaders, social feeds, and more information about our progress and commitment to developing innovative medicines ...

Jul 02, 2024 CARVYKTI ® is the first and only BCMA-targeted CAR-T cell therapy approved by the U.S. FDA for the treatment of patients with multiple myeloma who have had at least one prior line of therapy RARITAN, N.J., (July 2, 2024) /PRNewswire/ – ...

TAMAS ORAVECZ, Ph.D. SENIOR DIRECTOR HEAD OF EXPLORATORY BIOLOGY Tamas Oravecz, Ph.D., is Senior Director and Head of Exploratory Biology within Janssen BioTherapeutics (JBIO), Janssen Research & Development. He is based at Spring House, PA. His team ...

MICHAEL PLOTNICK, M.D. VICE PRESIDENT GLOBAL MEDICAL AFFAIRS IMMUNOLOGY Michael Plotnick, M.D. is Vice President, Global Medical Affairs for the Immunology Global Commercial Strategy Organization of Janssen Global Services. In this role, he leads a team ...

Our Fight Against Alzheimer’s September is World Alzheimer’s Month, a tradition that began in 2012 to draw attention to this devastating brain disease. It is easy to get discouraged about Alzheimer’s. Worldwide, nearly 44 million people have Alzheimer’s ...

256 SEARCH RESULTS FOR

faxtor 11 phase 3

Not finding what you're looking for? Visit Janssen in your country.
PAGE 19 OF 26

Pages